GE LUNAR DPX & PRODIGY SERIES DEXA BONE DENSITOMETERS WITH MOBILE KIT

K072439 · Ge Medical Systems Ultrasound and Primary Care Dia · KGI · Sep 14, 2007 · Radiology

Device Facts

Record IDK072439
Device NameGE LUNAR DPX & PRODIGY SERIES DEXA BONE DENSITOMETERS WITH MOBILE KIT
ApplicantGe Medical Systems Ultrasound and Primary Care Dia
Product CodeKGI · Radiology
Decision DateSep 14, 2007
DecisionSESE
Submission TypeSpecial
Regulation21 CFR 892.1170
Device ClassClass 2

Indications for Use

The GE Lunar DPX and Prodigy Series DEXA Bone Densitometers with Mobile Kit provides an estimate of bone mineral density and fat and lean tissue mass. The values can then be compared to a reference population at the sole discretion of the physician.

Device Story

GE Lunar DPX and Prodigy Series DEXA Bone Densitometers are general-purpose x-ray systems for bone mineral density and body composition assessment. The system includes a scan table for x-ray source generation, detection, and processing, controlled via a computer workstation. This modification introduces a mechanical hardware mobile kit, allowing the scanner to be mounted in a vehicle for transport and mobile clinical use. Operators (technicians/clinicians) use the system to acquire x-ray data, which is processed to estimate bone mineral density and tissue mass. Output is presented to the physician for comparison against reference populations to aid in clinical decision-making regarding bone health and body composition.

Clinical Evidence

No clinical tests were required to establish safety or effectiveness. Bench testing was performed using phantoms to verify in vitro precision and accuracy values were within design specifications.

Technological Characteristics

General purpose x-ray bone densitometer system. Components include a scan table (x-ray source, detector, processing unit) and a computer workstation. Modification includes mechanical hardware for vehicle mounting. Conforms to applicable medical device safety standards. Quality system conforms to 21 CFR 820 and ISO 13485.

Indications for Use

Indicated for the measurement of bone mineral density and fat and lean tissue mass in patients, with results compared to a reference population at the discretion of a physician.

Regulatory Classification

Identification

A bone densitometer is a device intended for medical purposes to measure bone density and mineral content by x-ray or gamma ray transmission measurements through the bone and adjacent tissues. This generic type of device may include signal analysis and display equipment, patient and equipment supports, component parts, and accessories.

Predicate Devices

Related Devices

Submission Summary (Full Text)

{0}------------------------------------------------ ## SEP 1 4 2007 K 072439 Special 510(k) Premarket Notification GE Medical Systems Lunar – DPX and Prodigy Series DEXA Bone Densitometers with Mobile Kit August 28th, 2007 510 (k) Summary of Safety and Effectiveness Prepared in accordance with 21 CFR Part 807.92(c). ## GE Healthcare Image /page/0/Picture/7 description: The image shows the General Electric (GE) logo. The logo consists of the letters 'g' and 'e' intertwined within a circular border. The logo is in black and white, with the letters and border appearing in white against a black background. ### Section a): | 1. | Submitter: | GE Medical Systems Ultrasound and Primary Care Diagnostics, LLC division of<br>General Electric Company<br>GE Medical Systems Lunar (business name)<br>726 Heartland Trail<br>Madison, WI 53717 | |----|----------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | | Contact Person: | James P. Raskob<br>Safety and Regulatory Engineering Manager<br>Telephone: 608-826-7425; Fax: 608-299-2132 | | | Date Prepared: | August 28th, 2007 | | 2. | Device Name: | GE Lunar DPX and Prodigy Series DEXA Bone Densitometers with Mobile Kit,<br>21 CFR 892.1170, 90-KGI | | 3. | Marketed Device: | DPX and Prodigy series bone densitometers: K915535 K982267 K983564<br>K000826 K001756 K001812 K011917 K023554 currently in commercial<br>distribution. | | 4. | Device Description: | The GE Lunar DPX and Prodigy Series DEXA Bone Densitometers with Mobile<br>Kit is a full-featured general purpose x-ray bone densitometer system. It<br>consists of a scan table that provides x-ray source generation, x-ray<br>detection and processing. The user interface includes a computer<br>workstation. This modification will provide users the option of mounting the<br>bone densitometer system into a vehicle through the use of a mechanical<br>hardware mobile kit used during the installation of the scanner and by the<br>Operator during transport. | | 5. | Indications for Use: | The GE Lunar DPX and Prodigy Series DEXA Bone Densitometers with Mobile Kit<br>provides an estimate of bone mineral density and fat and lean tissue mass. The<br>values can then be compared to a reference population at the sole discretion of | the physician. {1}------------------------------------------------ Special 510(k) Premarket Notification GE Medical Systems Lunar ~ DPX and Prodiqy Series DEXA Bone Densitometers with Mobile Kit August 28th, 2007 #### 6. Comparison with | Predicate Device: The GE Lunar DPX and Prodigy Series DEXA Bone Densitometers with Mobile | |-------------------------------------------------------------------------------------------| | Kit is of a comparable type and substantially equivalent to the current DPX and | | Prodigy series bone densitometers. It has the same technological | | characteristics, is comparable in key safety and effectiveness features, it | | utilizes similar design, construction, and materials, and has the same intended | | uses and basic operating modes as the predicate device. | #### Section b): - 1. Non-clinical Tests: The device has been evaluated for safety, and has been found to conform with applicable medical device safety standards. In vitro precision and accuracy values were computed through a series of tests on phantoms and were within design specifications. - 2. Clinical Tests: No clinical tests were required to establish safety or effectiveness. - 3. Conclusion: Intended uses and other key features are consistent with previously cleared bone densitometers. The design and development process of the manufacturer conforms with 21 CFR 820 and ISO 13485 quality systems. The device conforms to applicable medical device safety standards and compliance was verified through independent evaluation with ongoing factory surveillance. The GE Lunar DPX and Prodigy Series DEXA Bone Densitometer with Mobile Kit is substantially equivalent to currently marketed devices. No new safety and effectiveness questions are raised with the GE Lunar DPX and Prodigy Series DEXA Bone Densitometers with Mobile Kit option. {2}------------------------------------------------ Image /page/2/Picture/0 description: The image shows a logo on the left and the word "DEPARTMENT" on the right. The logo consists of a stylized eagle or bird-like figure with three curved lines representing its wings or feathers. The word "DEPARTMENT" is in a bold, sans-serif font, and it appears to be part of a larger heading or title. ## SEP 1 4 2007 Food and Drug Administration 9200 Corporate Blvd. Rockville MD 20850 Mr. James P. Raskob Safety and Regulatory Engineering Manager GE Medical Systems Lunar GE Healthcare 726 Heartland Trail MADISON WI 53717 Re: K072439 Trade/Device Name: GE Lunar DPX and Prodigy Series DEXA Bone Densitometer with Mobile Kit Regulation Number: 21 CFR 892.1190 Regulation Name: Bone densitometer Regulatory Class: II Product Code: KGI Dated: August 28, 2007 Received: August 30, 2007 Dear Mr. Raskob: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may. therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. Image /page/2/Picture/10 description: The image shows a circular logo with the text "1906-2006" at the top and "Centennial" at the bottom. The letters "FDA" are prominently displayed in the center of the logo. Below the logo, there is some text in a decorative font that reads "Protecting and Promoting Public Health." {3}------------------------------------------------ Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at one of the following numbers, based on the regulation number at the top of this letter: | 21 CFR 876.xxx | (Gastroenterology/Renal/Urology | 240-276-0115 | |----------------|---------------------------------|--------------| | 21 CFR 884.xxx | (Obstetrics/Gynecology) | 240-276-0115 | | 21 CFR 894.xxx | (Radiology) | 240-276-0120 | | Other | | 240-276-0100 | Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address http://www.fda.gov/cdrl/industry/support/index.html. Sincerely vours. Nancy Chrogdon Nancy C. Brogdon Director, Division of Reproductive. Abdominal, and Radiological Devices Office of Device Evaluation Center for Devices and Radiological Health {4}------------------------------------------------ Special 510{k} Premarket Notification GE Medical Systems Lunar – DPX and Prodigy Series DEXA Bone Densitometers with Mobile Kit August 28th, 2007 # Attachment E ## Indications for Use The GE Lunar DPX and Prodigy Series DEXA Bone Densitometers with Mobile Kit provide a measurement of bone mineral density and fat and lean tissue mass. The values can then be compared to a reference population at the sole discretion of the physician. Prescription Use XXX (Part 21 CFR 801 Subpart D) AND/OR Over-The-Counter Use (21 CFR 801 Subpart C) (P) EASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANQTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE) Hulu Lewen (Division Sign-Off) Division of Reproductive, Abdominal and Radiological Devices 510(k) Number K072439
Innolitics

Panel 1

/
Ready

Predicate graph will load when search results are available.

Embedding visualization will load when search results are available.

PDF viewer will load when search results are available.

Loading panels...

Select an item from Submissions

Click any panel, subpart, regulation, product code, or device to see details here.

Section Matches

Results will appear here.

Product Code Matches

Results will appear here.

Special Control Matches

Results will appear here.

Loading collections...